WillowWood Invests in Reboocon Bionics to Widen Access to the Intuy Powered Knee

18/11/2026
Above-knee prosthesis user wearing a Reboocon Intuy powered prosthetic knee, seated on a bench and checking his phonePhoto: Reboocon Bionics

WillowWood Global, the Ohio-based designer and manufacturer of lower limb prosthetic products, has made a strategic investment in Reboocon Bionics B.V., the Netherlands-based developer of the Intuy Knee, a motorised prosthetic knee. The deal was announced on 18 November 2026. Financial terms were not disclosed.

The investment deepens a relationship that began in January 2023, when the two companies formed a strategic alliance that made WillowWood the US distributor of the Intuy Knee and committed both firms to joint development and outcome studies. The partners now say they intend to advance clinical research, widen access for prosthetic practitioners and their patients, and accelerate the next generation of powered lower limb technology.

Why powered knees matter

Most prosthetic knees, including microprocessor-controlled designs, are passive: they control resistance but rely on the user to generate movement. A powered knee such as Intuy uses a motor to provide active assistance, which can help with tasks like rising from a chair, climbing stairs and walking up slopes. For people with transfemoral amputation or knee disarticulation, that can mean less compensatory effort from the sound limb and hips.

Daniel Rubin, Co-Chief Executive Officer of WillowWood, described powered technology as “one of the most meaningful opportunities to improve mobility” for people with above-knee amputations, and pointed to strong uptake of the Intuy Knee in the United States since its introduction. Shiqian Wang, Reboocon’s founder and CEO, called WillowWood an exceptional partner and the investment “an important milestone for Reboocon”.

Co-CEO Mahesh Mansukhani noted that he led work more than a decade ago to establish a US reimbursement pathway for powered prosthetic knees, and said the Intuy Knee is the kind of powered knee he had hoped the industry would deliver.

Private equity backing

The deal follows CVC Catalyst’s acquisition of a majority stake in WillowWood in June 2026. Marta Kowalska, a Director at CVC Capital Partners, said the firm was supporting the Reboocon investment to broaden the combined product portfolio and reach more patients worldwide. Coverage of the CVC deal indicated that WillowWood would pursue growth through acquisitions and international expansion, with Europe the most immediate opportunity.

IMEA CPO Perspective

The announcement is focused on the US market, and neither company has said when, or whether, the Intuy Knee will be distributed across the Middle East, Africa, Central Asia or South Asia. WillowWood already sells liners, feet and components through a worldwide distributor network, however, and a private-equity owner with stated international ambitions makes wider distribution of powered knees a realistic medium-term prospect.

For CPOs in the region, the more immediate issue is readiness. Powered knees demand careful patient selection, structured gait training and ongoing technical support, and they are only viable where a funding route exists. Mansukhani’s point about reimbursement is instructive: US access followed a dedicated payment pathway. In the GCC, public insurers and military and government programmes that already fund microprocessor knees for traumatic and conflict-related amputees are the natural place for such a pathway to start. Clinics that build outcome data and staff competence with high-end knees now will be best placed when powered options arrive.

The deal also shows mid-sized manufacturers using investment to compete with Ottobock and Össur in the high-end knee segment. More competition here could, over time, put downward pressure on prices for advanced components in emerging markets.

Sources and further reading

Leave a Reply